I partner with my clients to protect and advance innovations that help improve people’s lives

Experience

Degron Therapeutics’ $1.2 Billion Collaboration With Takeda

May 28, 2024

Cooley advised Degron Therapeutics on intellectual property due diligence matters in connection with its $1.2 billion collaboration agreement with Takeda Pharmaceuticals. Degron and Takeda will collaborate to utilize Degron’s GlueXplorer platform to identify, validate and optimize molecular glue degraders for specific therapeutic targets selected by Takeda.

Related contacts

Dr. Matthew Pavao
Partner, Boston
Chen Chen
Partner, Boston

Related Practices & Industries

Medicxi Invests $40 Million in D3 Bio

April 8, 2024

Cooley advised European life sciences investment firm Medicxi on its strategic $40 million investment in D3 Bio, a Shanghai-based biotechnology company focused on the discovery, development and registration of innovative medicines in oncology and immunology.

Related contacts

Chen Chen
Partner, Boston

Related Practices & Industries

Tectonic Therapeutic Announces Merger With AVROBIO, $130.7 Million Private Financing Commitments

January 30, 2024

Cooley advised Tectonic Therapeutic, a privately held biotechnology company developing G-protein coupled receptor-targeted therapeutic proteins, on its definitive merger agreement to combine in an all-stock transaction with AVROBIO, a gene therapy company with a purpose to free people from a lifetime of genetic disease. Tectonic also obtained $130.7 million in private financing commitments with a syndicate of new and existing leading life sciences investors in connection with the merger.

Read more

Related contacts

Miguel J. Vega
Partner, Boston
Marc Recht
Partner, Boston
Courtney Thorne
Partner, Boston
Michael Rohr
Partner, Boston
Dr. Matthew Pavao
Partner, Boston
Nyron J. Persaud
Partner, New York
Phil Mitchell
Partner, New York
Chen Chen
Partner, Boston
Sarah Lightdale
Partner, New York
Megan Browdie
Partner, Washington, DC
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
William Corcoran
Of Counsel, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Ryan Montgomery
Special Counsel, Boston

SystImmune Announces Global Strategic Collaboration With Bristol Myers Squibb

December 11, 2023

Cooley advised SystImmune, a clinical-stage biopharmaceutical company, on its exclusive license and collaboration agreement with Bristol Myers Squibb for SystImmune’s BL-B01D1.

Read more

Related contacts

Dr. Kate Hillier
Partner, Palo Alto
Lila Hope
Partner, Palo Alto
Chen Chen
Partner, Boston
Aaron Pomeroy
Partner, Colorado
Todd Gluth
Partner, San Diego
Rick Jantz
Associate, Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Zack Gong
Associate, Shanghai
Rena Kaminsky
Special Counsel, Palo Alto
Freddy Yip
Associate, Hong Kong
David D. Suh
Associate
David Burns
Special Counsel, Washington, DC
Rubin Waranch
Associate, Colorado
Andrew Epstein
Special Counsel, Seattle
Daniel Millard
Associate, London
Zhijing Yu
Associate, Singapore
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC

Related Practices & Industries

Eccogene Enters Exclusive License Agreement With AstraZeneca

November 9, 2023

Cooley advised Eccogene on its strategic collaboration and license agreement with AstraZeneca, a global biopharmaceutical company. Eccogene will receive an initial upfront payment of $185 million and will also be eligible to receive up to $1.825 billion in future clinical, regulatory and commercial milestones, as well as royalty payments.

Related contacts

Chen Chen
Partner, Boston
Geoffrey Biegler
Partner, San Diego

Related Practices & Industries

View more

Memberships and affiliations

American Bar Association (ABA)

Boston Patent Law Association